Mesalamine Tablet, Delayed Release
Product Images NDC 65162-360

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 65162-360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Mesalamine Delayed Release Tablets Usp 800 mg 1)

This is a compound with a molecular weight of approximately 153.1 g/mol and a molecular formula of C3H7NO.*

FDA Label Image

Label (Mesalamine Delayed Release Tablets Usp 800 mg 2)

This is a prescription medication for Mesalamine in the form of Delayed-Release Tablets. Each tablet contains 800 mg of Mesalamine. It is used for the treatment of moderately active ulcerative colitis. The recommended dose is 1,600 mg (two 800 mg tablets) three times daily. The tablets should be swallowed whole and not cut, broken, or chewed. It is important not to substitute this medication for other forms of Mesalamine. Store at a temperature between 20°C to 25°C. Additional prescribing information can be found in the package insert. Distributed by Amneal Pharmaceuticals LLC.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.